Literature DB >> 3960439

Papillary serous adenocarcinoma of the endometrium.

J F Jeffrey, G V Krepart, R J Lotocki.   

Abstract

The clinical outcome of 15 women with papillary serous adenocarcinoma of the endometrium is presented. In 14 instances the diagnosis was made by uterine curettage. Eight cases (53.3%) were clinically understaged based on laparotomy findings. Intraoperative assessment for extrauterine spread of disease was infrequently performed. Recurrent disease developed in 12 patients (80.0%) with ten arising within the abdomen either alone or in conjunction with another site. Eleven patients (73.3%) have died of disease and two of the four alive have been treated for a recurrence. The need to determine appropriate adjuvant therapy for patients with this disease exists. A protocol for patient management is proposed.

Entities:  

Mesh:

Year:  1986        PMID: 3960439     DOI: 10.1097/00006250-198605000-00013

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  [Endometrial cancer stages I and II--surgical treatment].

Authors:  O Käser
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

2.  Management of women with surgically staged 1 uterine papillary serous cancer.

Authors:  Laurie Elit; Andre Laroche; Lauren Smith; John Mazurka; Francois Moens; Jan Hauspy; Waldo Jimenez
Journal:  ISRN Obstet Gynecol       Date:  2011-09-11

Review 3.  The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic review.

Authors:  Valentina Lancellotta; Francesca De Felice; Lisa Vicenzi; Alfredo Antonacci; Valentina Cerboneschi; Sara Costantini; Daniela di Cristino; Luca Tagliaferri; Annamaria Cerrotta; Andrea Vavassori; Sergio Gribaudo; Alessandro Colombo; Francesco Lucà; Raffaele Barbara; Monica Mangoni; Francesco Marampon; Daniela Musio; Filippo Bellati; Francesco Torcia; Vincenzo Tombolini; Mattia Falchetto Osti; Vitaliana De Sanctis
Journal:  J Contemp Brachytherapy       Date:  2020-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.